Effective Management of Calcific Aortic Stenosis in the Elderly

French Cardiology Society1,101 enrolled

Overview

Although aortic valve replacement is recommended for any symptomatic severe calcific aortic stenosis, the therapeutic decision may be difficult. because of patient age and comorbidities. Transcatheter Aortic Valve Implantation (TAVI) has recently extended the therapeutic indications in patients at high risk of surgery. However, the proportion of different treatments is not known in a contemporary population that can be treated according to the different resources currently available. The scientific goal of this observational research is to evaluate intra-hospital therapeutic decision in elderly patients referred because of symptomatic severe aortic stenosis. The one-year survival will be analyzed according to the therapeutic decision and the characteristics of the patients.

Study Type

OBSERVATIONAL

Enrollment

1,101

Conditions

Calcific Aortic Stenosis

Eligibility

Sex: ALLMin age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Hospitalized due to symptomatic tight aortic stenosis (NYHA \>= II, dyspnea, angina or syncope); * Having given his consent to participate in the study. Exclusion Criteria: * Non-severe aortic stenosis; * Asymptomatic aortic stenosis; * Patient under the age of 75; * Patient refusing to participate in the study.

Outcomes

Primary Outcomes

Collate the therapeutic decision (medical treatment, TAVI [Transcatheter Aortic Valve Implantation] or surgical aortic valve replacement) comprehensively for all hospitalized patients because of a severe, symptomatic RAC.

Secondary Outcomes

1 year-survival

Survival at one year will be analyzed. The analysis of the relationship between therapeutic decision and survival will be studied by taking surgical aortic valve replacement as a reference class.

Time frame: 1 year